Alan Nafiiev

Alan is the CEO at Receptor.AI, a drug discovery company he co-founded in 2021. He has used his skills in integrating AI, molecular simulations, and advanced experimental techniques to create the company's innovative hybrid intelligence drug discovery platform. He holds a PhD in data science education from Kyiv Polytechnic University, further solidifying his knowledge and expertise in the AI field.
Avatar photo

Posts by Alan Nafiiev

Simulation / Modeling / Design

Accelerating Drug Discovery at Receptor.AI with NVIDIA BioNeMo Cloud APIs

The quest for new, effective treatments for diseases that remain stubbornly resistant to current therapies is at the heart of drug discovery. This traditionally... 11 MIN READ